Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Stem cell therapy shows promise in improving burn wound healing.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Stem cell therapies show promise for treating hair loss, but more research is needed to understand their safety and effectiveness.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

New gene variants linked to a rare inherited hair loss disorder were found in three Chinese families.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

AMH levels in adolescents with PCOS are not affected by their weight.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

The document concludes that using stem cells to regenerate hair follicles could be a promising treatment for hair loss, but there are still challenges to overcome before it can be used clinically.

A new genetic change in the keratin 10 gene caused a skin condition called ichthyosis hystrix in a father and his daughter.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.